These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26980486)

  • 1. The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
    Anastasiadou S; Knöll B
    Exp Neurol; 2016 May; 279():243-260. PubMed ID: 26980486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS axon regeneration inhibitors stimulate an immediate early gene response via MAP kinase-SRF signaling.
    Stern S; Knöll B
    Mol Brain; 2014 Nov; 7():86. PubMed ID: 25406759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.
    Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M
    J Neurovirol; 2017 Dec; 23(6):808-824. PubMed ID: 28913617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
    Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
    J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor serum response factor stimulates axon regeneration through cytoplasmic localization and cofilin interaction.
    Stern S; Haverkamp S; Sinske D; Tedeschi A; Naumann U; Di Giovanni S; Kochanek S; Nordheim A; Knöll B
    J Neurosci; 2013 Nov; 33(48):18836-48. PubMed ID: 24285890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing.
    Das A; Arifuzzaman S; Kim SH; Lee YS; Jung KH; Chai YG
    Neuropharmacology; 2017 Jun; 119():1-14. PubMed ID: 28373076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
    Ottenlinger F; Schwiebs A; Pfarr K; Wagner A; Grüner S; Mayer CA; Pfeilschifter JM; Radeke HH
    Eur J Immunol; 2016 Apr; 46(4):941-51. PubMed ID: 26683421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis.
    Turgut GÇ; Doyduk D; Yıldırır Y; Yavuz S; Akdemir A; Dişli A; Şen A
    Bioorg Med Chem; 2017 Jan; 25(2):483-495. PubMed ID: 27913115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
    Mazzola MA; Raheja R; Murugaiyan G; Rajabi H; Kumar D; Pertel T; Regev K; Griffin R; Aly L; Kivisakk P; Nejad P; Patel B; Gwanyalla N; Hei H; Glanz B; Chitnis T; Weiner HL; Gandhi R
    J Neuroinflammation; 2015 Dec; 12():245. PubMed ID: 26714756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
    Szepanowski F; Derksen A; Steiner I; Meyer Zu Hörste G; Daldrup T; Hartung HP; Kieseier BC
    J Neuroinflammation; 2016 Jun; 13(1):143. PubMed ID: 27283020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
    Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
    Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons.
    Bomze HM; Bulsara KR; Iskandar BJ; Caroni P; Skene JH
    Nat Neurosci; 2001 Jan; 4(1):38-43. PubMed ID: 11135643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
    Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
    J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
    Schröder M; Arlt O; Schmidt H; Huwiler A; Angioni C; Pfeilschifter JM; Schwiebs A; Radeke HH
    Biol Chem; 2015 Jun; 396(6-7):795-802. PubMed ID: 25720062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
    Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH
    JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fingolimod (FTY720) prevents chronic rejection of rodent cardiac allografts through inhibition of the RhoA pathway.
    Chen W; Chen W; Chen S; Uosef A; Ghobrial RM; Kloc M
    Transpl Immunol; 2021 Apr; 65():101347. PubMed ID: 33131698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
    Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
    Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
    Heinen A; Beyer F; Tzekova N; Hartung HP; Küry P
    Exp Neurol; 2015 Sep; 271():25-35. PubMed ID: 25957629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720 attenuates excitotoxicity and neuroinflammation.
    Cipriani R; Chara JC; Rodríguez-Antigüedad A; Matute C
    J Neuroinflammation; 2015 May; 12():86. PubMed ID: 25953296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephrin-A5 suppresses neurotrophin evoked neuronal motility, ERK activation and gene expression.
    Meier C; Anastasiadou S; Knöll B
    PLoS One; 2011; 6(10):e26089. PubMed ID: 22022520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.